Jun 2026 (Q2 FY26) — Aug 6, 2026
OmniAb Q2 FY26 — Strong Performance Driven by Partner Program Advancements and Exploration Sales
Read the full callOmniAb (OABI) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
OmniAb earnings: last reported Thu, 6 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 13.4 | +244.2% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -49.5 | +366.7 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -5.9 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$4.69 +2.18% · +$0.1
Performance +182.5% 1Y
1Y: $1.66 on 17 Oct 2025 → $4.69. High $5.04 (2 Sept 2026), low $1.36 (29 Apr 2026).
- Previous close
- $4.59
- 52-week range
- $1.36 – $5.04
- One year
- +171.10%
Overview
- Symbol
- OABI
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
OmniAb earnings calls (OABI)
Financials
What the filings say
Net profit, year on year: +63% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 4 | 11 | 4 | 4 | 2 | 8 | 14 | 13 |
| Operating profit | -20 | -16 | -19 | -16 | -18 | -16 | -8 | -7 |
| Operating margin | −473.7% | −147.0% | −453.6% | −416.2% | −810.2% | −188.2% | −54.3% | −49.5% |
| Other income | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 |
| Profit before tax | -19 | -15 | -18 | -16 | -18 | -15 | -7 | -6 |
| Tax rate | 14.2% | 14.2% | 0.6% | −0.8% | 6.6% | 2.5% | −6.1% | 5.7% |
| Net profit | -16 | -13 | -18 | -16 | -17 | -14 | -8 | -6 |
| EPS ($ per share) | -0.16 | — | -0.17 | -0.15 | -0.14 | — | -0.06 | -0.05 |
| Line item | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 |
| Reserves | 0 | 11 | -39 | -101 | -166 |
| Total liabilities | 70 | 80 | 61 | 38 | 34 |
| Fixed assets | 7 | 20 | 18 | 15 | 9 |
| Total assets | 304 | 421 | 375 | 326 | 301 |
| Line item | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Cash from operations | -6 | -4 | 2 | -40 | -36 |
| Cash from investing | -4 | -73 | -18 | 38 | 6 |
| Cash from financing | 10 | 111 | -1 | 13 | 28 |
| Net cash flow | 0 | 34 | -17 | 11 | -2 |
| Capital expenditure | -4 | -17 | -2 | -2 | -1 |
| Free cash flow | -10 | -21 | 1 | -42 | -37 |
Insider filings
37 filings between Nov 1, 2025 and Jun 17, 2026.
Open market
decisions to buy or sellPurchases
$107.7K
2 purchases by 1 insider
Sales
$283.0K
12 sales by 3 insiders
Compensation
not trading decisions- 23
- Option exercise — converted options into shares
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| FOEHR MATTHEW W | — | $143.5K | Apr 7, 2026 |
| HIGGINS JOHN L | $107.7K | — | Nov 7, 2025 |
| GUSTAFSON KURT A | — | $84.7K | Apr 7, 2026 |
| Berkman Charles S | — | $54.9K | Apr 7, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Jun 17, 2026 | Bertozzi Carolyn R Director | Option exercise | 20,000 | — |
| Jun 17, 2026 | Cochran Jennifer R. Director | Option exercise | 20,000 | — |
| Jun 17, 2026 | HIGGINS JOHN L Director | Option exercise | 20,000 | — |
| Jun 17, 2026 | Gotwals Philip J Director | Option exercise | 20,000 | — |
| Jun 17, 2026 | Crouse Steven C. Director | Option exercise | 20,000 | — |
| Jun 17, 2026 | Love Steven Director | Option exercise | 20,000 | — |
| Apr 21, 2026 | Gotwals Philip J Director | Option exercise | 13,333 | — |
| Apr 21, 2026 | Crouse Steven C. Director | Option exercise | 13,333 | — |
| Apr 7, 2026 | Berkman Charles S Chief Legal Officer | Option exercise | 13,542 | $0 |
| Apr 7, 2026 | Berkman Charles S Chief Legal Officer | Sale | 7,157 | $10.7K |
| Apr 7, 2026 | GUSTAFSON KURT A Executive VP, Finance and CFO | Option exercise | 13,542 | $0 |
| Apr 7, 2026 | GUSTAFSON KURT A Executive VP, Finance and CFO | Sale | 6,913 | $10.3K |
| Apr 7, 2026 | FOEHR MATTHEW W President and CEO | Option exercise | 36,459 | $0 |
| Apr 7, 2026 | FOEHR MATTHEW W President and CEO | Sale | 19,244 | $28.7K |
| Feb 18, 2026 | GUSTAFSON KURT A Executive VP, Finance and CFO | Sale | 9,301 | $15.9K |
| Feb 18, 2026 | FOEHR MATTHEW W President and CEO | Option exercise | 58,333 | — |
| Feb 18, 2026 | FOEHR MATTHEW W President and CEO | Sale | 30,843 | $52.7K |
| Feb 18, 2026 | Berkman Charles S Chief Legal Officer | Option exercise | 18,750 | $0 |
| Feb 18, 2026 | Berkman Charles S Chief Legal Officer | Sale | 9,673 | $16.5K |
| Feb 18, 2026 | GUSTAFSON KURT A Executive VP, Finance and CFO | Option exercise | 18,750 | $0 |
| Feb 17, 2026 | GUSTAFSON KURT A Executive VP, Finance and CFO | Sale | 6,828 | $11.6K |
| Feb 17, 2026 | Berkman Charles S Chief Legal Officer | Sale | 6,990 | $11.9K |
| Feb 17, 2026 | FOEHR MATTHEW W President and CEO | Sale | 20,754 | $35.3K |
| Feb 16, 2026 | Berkman Charles S Chief Legal Officer | Option exercise | 13,542 | $0 |
| Feb 16, 2026 | GUSTAFSON KURT A Executive VP, Finance and CFO | Option exercise | 13,542 | $0 |
| Feb 16, 2026 | FOEHR MATTHEW W President and CEO | Option exercise | 36,458 | $0 |
| Jan 30, 2026 | HIGGINS JOHN L Director | Option exercise | 13,172 | — |
| Dec 8, 2025 | GUSTAFSON KURT A Executive VP, Finance and CFO | Sale | 23,922 | $46.9K |
| Dec 8, 2025 | FOEHR MATTHEW W President and CEO | Sale | 13,666 | $26.8K |
| Dec 8, 2025 | Berkman Charles S Chief Legal Officer | Sale | 8,044 | $15.8K |
| Dec 7, 2025 | Berkman Charles S Chief Legal Officer | Option exercise | 15,621 | $0 |
| Dec 7, 2025 | FOEHR MATTHEW W President and CEO | Option exercise | 26,554 | $0 |
| Dec 7, 2025 | GUSTAFSON KURT A Executive VP, Finance and CFO | Option exercise | 46,500 | $0 |
| Nov 7, 2025 | HIGGINS JOHN L Director | Purchase | 41,038 | $56.6K |
| Nov 6, 2025 | HIGGINS JOHN L Director | Purchase | 36,223 | $51.1K |
| Nov 1, 2025 | Love Steven Director | Option exercise | 13,333 | — |
| Nov 1, 2025 | Bertozzi Carolyn R Director | Option exercise | 17,769 | — |
| Aug 26, 2025 | FOEHR MATTHEW W President and CEO | Award | 540,540 | $1000.0K |
| Jun 17, 2025 | Cochran Jennifer R. Director | Option exercise | 20,000 | — |
| Jun 17, 2025 | HIGGINS JOHN L Director | Option exercise | 20,000 | — |
| Jun 17, 2025 | Love Steven Director | Option exercise | 20,000 | — |
| Jun 17, 2025 | Bertozzi Carolyn R Director | Option exercise | 20,000 | — |
| May 15, 2025 | Cochran Jennifer R. Director | Purchase | 30,000 | $45.6K |
| May 14, 2025 | Love Steven Director | Purchase | 25,000 | $36.5K |
| May 12, 2025 | HIGGINS JOHN L Director | Purchase | 65,000 | $93.6K |
| Apr 7, 2025 | GUSTAFSON KURT A Executive VP, Finance and CFO | Option exercise | 13,542 | $0 |
| Apr 7, 2025 | GUSTAFSON KURT A Executive VP, Finance and CFO | Sale | 7,206 | $14.4K |
| Apr 7, 2025 | Berkman Charles S Chief Legal Officer | Option exercise | 13,542 | $0 |
| Apr 7, 2025 | Berkman Charles S Chief Legal Officer | Sale | 7,206 | $14.4K |
| Apr 7, 2025 | FOEHR MATTHEW W President and CEO | Option exercise | 36,458 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for OmniAb, Inc.
Free account. Everything above stays public.
Write why you follow OmniAb, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading